RGLS – regulus therapeutics inc. (US:NASDAQ)
Stock Stats
News
Polycystic Kidney Diseases Therapeutics Market Report 2024: Comprehensive Insights About 8+ Companies and 10+ Pipeline Drugs [Yahoo! Finance]
Regulus Therapeutics Announces Participation at Upcoming Healthcare Investment Conferences [Yahoo! Finance]
Regulus Therapeutics Announces Participation at Upcoming Healthcare Investment Conferences
Regulus Therapeutics Inc. (NASDAQ: RGLS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Regulus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Updates
Form SC 13G/A Regulus Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
Form SC 13G/A Regulus Therapeutics Filed by: BIOTECHNOLOGY VALUE FUND L P
Form SC 13G/A Regulus Therapeutics Filed by: DAFNA Capital Management LLC
Form SC 13G/A Regulus Therapeutics Filed by: VANGUARD GROUP INC
Form SC 13G Regulus Therapeutics Filed by: BlackRock, Inc.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.